Oro-CV 625 Tablet is a combination antibiotic formulation containing Amoxycillin 500 mg and Clavulanic Acid 125 mg. Amoxycillin is a broad-spectrum penicillin-class antibiotic effective against a variety of gram-positive and gram-negative bacteria, functioning by inhibiting bacterial cell wall synthesis. Clavulanic Acid is a beta-lactamase inhibitor that protects Amoxycillin from enzymatic degradation by beta-lactamase-producing bacteria, thereby extending its spectrum of activity. This combination is indicated for the treatment of infections caused by susceptible strains, including respiratory tract infections (such as sinusitis, otitis media, bronchitis, and pneumonia), urinary tract infections, skin and soft tissue infections, and dental infections. Oro-CV 625 Tablet is administered orally, with dosage and duration tailored according to the severity and type of infection, patient age, and renal function. It is essential to complete the full prescribed course to prevent the development of resistance. Common adverse effects may include gastrointestinal disturbances like diarrhea, nausea, and vomiting. Hypersensitivity reactions, including rash and anaphylaxis, though rare, require immediate medical attention. Caution is advised in patients with a history of penicillin allergy or hepatic impairment. This medication should be used under medical supervision to ensure safe and effective therapy.